Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBOT | AZN | AMGN | GILD | VRTX |
| Company | Bridgebio Oncology Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 11.18 | 92.06 | 346.18 | 131.26 | 465.23 |
| High | 12.67 | 92.99 | 349.23 | 136.30 | 470.34 |
| Low | 10.88 | 91.44 | 341.82 | 131.00 | 462.73 |
| Latest | 12.62 | 92.95 | 344.75 | 135.93 | 468.41 |
| Change | +1.37 | +1.26 | -2.32 | +4.79 | +1.06 |
| % Change | +12.18% | +1.37% | -0.67% | +3.65% | +0.23% |
| Volume | 419,200 | 4,322,800 | 2,024,900 | 13,180,899 | 1,330,000 |
| 20-Day Average Volume | 351,115 | 8,228,985 | 2,352,085 | 6,181,545 | 1,315,005 |
| Previous Close | 11.25 | 91.69 | 347.07 | 131.14 | 467.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.08 | 93.09 | 331.73 | 124.18 | 458.19 |
| 20-Day Raw Stochastic | 51.80% | 52.34% | 83.54% | 98.09% | 67.34% |
| 20-Day Relative Strength | 53.41 | 53.25 | 60.34 | 65.80 | 57.56 |
| Weighted Alpha | +19.60 | +37.26 | +28.05 | +46.52 | +9.92 |
| Today's Opinion | 72% Buy | 80% Buy | 88% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 8% Buy | 80% Buy | 88% Buy | 100% Buy | 80% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 88% Buy | 88% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.74% since 01/15/26 | -1.11% since 01/15/26 | +4.46% since 01/15/26 | +12.10% since 01/15/26 | +6.72% since 01/15/26 |
| Low | 10.88 on 01/23/26 | 89.04 on 01/21/26 | 321.71 on 01/20/26 | 122.10 on 01/16/26 | 429.00 on 01/20/26 |
| High | 12.67 on 01/23/26 | 94.68 on 01/16/26 | 349.98 on 01/22/26 | 136.30 on 01/23/26 | 472.58 on 01/22/26 |
| 1-Month | |||||
| %Chg | +5.78% since 12/23/25 | +0.88% since 12/23/25 | +4.00% since 12/23/25 | +8.58% since 12/23/25 | +2.00% since 12/23/25 |
| Low | 10.49 on 01/05/26 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 14.60 on 01/09/26 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 136.30 on 01/23/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +16.10% since 10/23/25 | +11.45% since 10/23/25 | +17.71% since 10/23/25 | +12.58% since 10/23/25 | +10.83% since 10/23/25 |
| Low | 10.49 on 01/05/26 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 14.87 on 12/08/25 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 136.30 on 01/23/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +18.05% since 07/23/25 | +27.33% since 07/23/25 | +11.49% since 07/23/25 | +19.70% since 07/23/25 | -1.79% since 07/23/25 |
| Low | 8.50 on 08/05/25 | 71.49 on 07/28/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 14.87 on 12/08/25 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 136.30 on 01/23/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,009,461 | 288,313,792 | 185,641,344 | 168,645,632 | 118,844,512 |
| Shares Outstanding, K | 79,989 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -74,275,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -44,760,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.12 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 11/12/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/11/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.06 | 15.87 | 16.01 | 30.53 |